Pelthos Therapeutics Inc. (PTHS)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $29.24M
Last updated: Nov 17, 2026 at 11:04 AM ET
Pelthos Therapeutics Inc. (PTHS) Competitors
The companies most similar to Pelthos Therapeutics are Plus Therapeutics (PSTV), Pliant Therapeutics (PLRX) and Grace Therapeutics (GRCE). By market cap, Pelthos Therapeutics ranks 9th of the 13 companies on this page; Gain Therapeutics (GANX) is the largest at $46.31M.
Peer Comparison
PTHS's ROIC of -95.4% is above the peer median of -170.5%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Pelthos Therapeutics (PTHS) | $29.24M | N/A | 0.5x | -199.5% | -95.4% | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Pliant Therapeutics Inc (PLRX) | $43.21M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Pasithea Therapeutics Corp (KTTA) | $17.44M | N/A | N/A | 0.0% | N/A | 1498.0% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| Quince Therapeutics, Inc. (QNCX) | $32.27M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Transcode Therapeutics Inc (RNAZ) | $22.35M | N/A | N/A | 0.0% | -412.7% | 0.0% | 0.00% |
| ProMIS Neurosciences Inc. (PMN) | $29.60M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Immutep Ltd ADR (IMMP) | $25.64M | N/A | 2.2x | 0.0% | N/A | 633.0% | 0.00% |
| Serina Therapeutics Inc (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| Peer median | $33.57M | N/A | 2.2x | 0.0% | -170.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Pelthos Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Pliant Therapeutics Inc (PLRX) | Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops... | PLRX competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| Pasithea Therapeutics Corp (KTTA) | Pasithea Therapeutics Corp. The company is headquartered in Miami Beach, Florida. | KTTA competitors |
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| Quince Therapeutics, Inc. (QNCX) | Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases. | |
| Transcode Therapeutics Inc (RNAZ) | TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic... | RNAZ competitors |
| ProMIS Neurosciences Inc. (PMN) | ProMIS Neurosciences Inc. is a pioneering biotechnology company focused on the development of innovative therapeutic solutions for neurodegenerative diseases... | PMN competitors |
| Immutep Ltd ADR (IMMP) | Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates. | |
| Serina Therapeutics Inc (SER) | Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology... | SER competitors |
Frequently Asked Questions About PTHS
Who are Pelthos Therapeutics' main competitors?
The companies most similar to Pelthos Therapeutics include Plus Therapeutics (PSTV), Pliant Therapeutics (PLRX), Grace Therapeutics (GRCE), Gain Therapeutics (GANX) and Telomir Pharmaceuticals, Inc. Common Stock (TELO), listed from the closest match.
Who is Pelthos Therapeutics' biggest competitor?
Gain Therapeutics (GANX) is the largest of the similar companies at $46.31M; Plus Therapeutics (PSTV) is the closest match by business profile, size, sector and industry.
How does PTHS stock compare with its competitors?
PTHS' P/S is 0.5x against a peer median of 2.2x; its net margin is -199.5% against a peer median of 0.0%.
Which of Pelthos Therapeutics' competitors pays a higher dividend?
Pelthos Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Pelthos Therapeutics bigger than its competitors?
No. Pelthos Therapeutics is 9th by market cap among the 13 companies on this page; the largest is Gain Therapeutics (GANX) at $46.31M.
PTHS pages: Overview, Earnings, Forecast, Financials, Competitors